Terms: = Lung cancer AND RAP1GDS1, P52306, 5910, MGC118861, MGC118859, GDS1, ENSG00000138698
20 results:
1. Lymph node metastasis risk factors in clinical stage IA3 lung adenocarcinoma.
Zheng Y; Ju S; Huang R; Zhao J
J Cancer Res Ther; 2023 Feb; 19(1):34-38. PubMed ID: 37006040
[TBL] [Abstract] [Full Text] [Related]
2. WDR74 rs11231247 contributes to the susceptibility and prognosis of non-small cell lung cancer.
Wu F; Wu H; Hu W; Zhang Z; Zhang X
Pathol Res Pract; 2023 Feb; 242():154318. PubMed ID: 36701849
[TBL] [Abstract] [Full Text] [Related]
3. Retrospective Data Analysis of Patients With Metastatic lung Adenocarcinoma With or Without
Moeller M; Schaedlich F; Schuette W
Cancer Control; 2022; 29():10732748221126949. PubMed ID: 36355617
[TBL] [Abstract] [Full Text] [Related]
4. [Analysis of the relationship between the anatomical location of intrapulmonary metastatic lymph nodes and relapse risk and survival in patients with N1 non-small cell lung cancer].
Zhao DC; Yan S; Wang YQ; Ma YY; Wang X; Li SL; Li X; Lyu C; Wang YZ; Wang J; Yang Y; Wu N
Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(35):2778-2786. PubMed ID: 34551494
[No Abstract] [Full Text] [Related]
5. Prognostic and clinicopathological value of PD-L2 in lung cancer: A meta-analysis.
Lin X; Lin K; Lin C; Liu T; Ba M; Tang Y; Wang J; Zhou L; Wang J; Xiao C
Int Immunopharmacol; 2021 Feb; 91():107280. PubMed ID: 33370681
[TBL] [Abstract] [Full Text] [Related]
6. Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell lung cancer and EGFR-Activating Mutations.
Mok TS; Cheng Y; Zhou X; Lee KH; Nakagawa K; Niho S; Chawla A; Rosell R; Corral J; Migliorino MR; Pluzanski A; Noonan K; Tang Y; Pastel M; Wilner KD; Wu YL
Drugs; 2021 Feb; 81(2):257-266. PubMed ID: 33331989
[TBL] [Abstract] [Full Text] [Related]
7. Combined Proteomic and Genetic Interaction Mapping Reveals New RAS Effector Pathways and Susceptibilities.
Kelly MR; Kostyrko K; Han K; Mooney NA; Jeng EE; Spees K; Dinh PT; Abbott KL; Gwinn DM; Sweet-Cordero EA; Bassik MC; Jackson PK
Cancer Discov; 2020 Dec; 10(12):1950-1967. PubMed ID: 32727735
[TBL] [Abstract] [Full Text] [Related]
8. Splice switching an oncogenic ratio of SmgGDS isoforms as a strategy to diminish malignancy.
Brandt AC; McNally L; Lorimer EL; Unger B; Koehn OJ; Suazo KF; Rein L; Szabo A; Tsaih SW; Distefano MD; Flister MJ; Rigo F; McNally MT; Williams CL
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3627-3636. PubMed ID: 32019878
[TBL] [Abstract] [Full Text] [Related]
9. Burden of Cause-Specific Mortality Associated With PM2.5 Air Pollution in the United States.
Bowe B; Xie Y; Yan Y; Al-Aly Z
JAMA Netw Open; 2019 Nov; 2(11):e1915834. PubMed ID: 31747037
[TBL] [Abstract] [Full Text] [Related]
10. [Results of lung cancer Screening among Urban Residents in Kunming].
Lin Y; Ma J; Feng J; Zhang Q; Huang Y
Zhongguo Fei Ai Za Zhi; 2019 Jul; 22(7):413-418. PubMed ID: 31315779
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of rare and complex mutations in EGFR and serum levels of soluble EGFR and its ligands in non-small cell lung carcinoma patients.
Haghgoo SM; Khosravi A; Mortaz E; Pourabdollah-Toutkaboni M; Seifi S; Sabour S; Allameh A
Clin Biochem; 2017 Apr; 50(6):293-300. PubMed ID: 27923629
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of 99mTc-3PRGD2 integrin receptor imaging with 99mTc-MDP bone scan in diagnosis of bone metastasis in patients with lung cancer: a multicenter study.
Miao W; Zheng S; Dai H; Wang F; Jin X; Zhu Z; Jia B
PLoS One; 2014; 9(10):e111221. PubMed ID: 25338281
[TBL] [Abstract] [Full Text] [Related]
13. Cost-effectiveness of follow-up of pulmonary nodules incidentally detected on cardiac computed tomographic angiography in patients with suspected coronary artery disease.
Goehler A; McMahon PM; Lumish HS; Wu CC; Munshi V; Gilmore M; Chung JH; Ghoshhajra BB; Mark D; Truong QA; Gazelle GS; Hoffmann U
Circulation; 2014 Aug; 130(8):668-75. PubMed ID: 25015342
[TBL] [Abstract] [Full Text] [Related]
14. SmgGDS-558 regulates the cell cycle in pancreatic, non-small cell lung, and breast cancers.
Schuld NJ; Hauser AD; Gastonguay AJ; Wilson JM; Lorimer EL; Williams CL
Cell Cycle; 2014; 13(6):941-52. PubMed ID: 24552806
[TBL] [Abstract] [Full Text] [Related]
15. New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma.
Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
J Thorac Oncol; 2013 May; 8(5):612-8. PubMed ID: 23584293
[TBL] [Abstract] [Full Text] [Related]
16. Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance.
Okudela K; Woo T; Mitsui H; Tajiri M; Masuda M; Ohashi K
Pathol Int; 2012 Dec; 62(12):792-801. PubMed ID: 23252868
[TBL] [Abstract] [Full Text] [Related]
17. Chronic effects of environmental biomass smoke on lung histopathology in Turkish non-smoking women: a case series.
Gunbatar H; Sertogullarindan B; Ozbay B; Avcu S; Bulut G; Kosem M
Arh Hig Rada Toksikol; 2012 Sep; 63(3):357-65. PubMed ID: 23152385
[TBL] [Abstract] [Full Text] [Related]
18. Quantitative analysis of thymidine kinase 1 and 5'(3')-deoxyribonucleotidase mRNA expression: the role of fluorothymidine uptake.
Lee SJ; Lee HJ; Moon DH
Anticancer Res; 2011 Jun; 31(6):2135-9. PubMed ID: 21737633
[TBL] [Abstract] [Full Text] [Related]
19. [Clinical characteristics and treatment analysis of primary breast lymphoma: 49 cases report].
Qiu LH; Wang HQ; Qian ZZ; Li W; Hou Y; Meng XR; Cui XZ; Hao XS
Zhonghua Wai Ke Za Zhi; 2010 May; 48(10):743-6. PubMed ID: 20646489
[TBL] [Abstract] [Full Text] [Related]
20. Identification of differentially expressed genes in human lung squamous cell carcinoma using suppression subtractive hybridization.
Sun W; Zhang K; Zhang X; Lei W; Xiao T; Ma J; Guo S; Shao S; Zhang H; Liu Y; Yuan J; Hu Z; Ma Y; Feng X; Hu S; Zhou J; Cheng S; Gao Y
Cancer Lett; 2004 Aug; 212(1):83-93. PubMed ID: 15246564
[TBL] [Abstract] [Full Text] [Related]
